Candesartanum cilexetilum, Hydrochlorothiazidum
| Medicinal product name | Atacand Plus 16 mg/12.5 mg tablets |
|---|---|
| Pharmaceutical form | Tablet |
| Strength | 16 mg/12.5 mg |
| Information from the MAH on shortages | Not notified |
| Legal status | Prescription (Pr.) |
| Package leaflet |  05-12-2023
|
| Summary of product characteristics | 25-07-2023
|
| Risk minimisation measures | Vēstule veselības aprūpes speciālistam |
| ATC code | C09DA06 – Agents acting on the renin-angiotensin system |
| Information for Marketing authorisation holders | View |
Medicinal products (18)
| Availability of medicinal product | Wholesalers | Package size, content | Primary packaging | Maximum admissible pharmacy price (€ incl. VAT) | Product No. | Labelling |
|---|---|---|---|---|---|---|
| Not available (according to the information provided by wholesalers) | currently no information on availability from any wholesaler |
N100 (16 mg/12,5 mg) |
HDPE bottle | 11-0413-01 |
Labelling text Jul 25, 2023 Labelling text Jul 25, 2023 |
|
|
Not available (according to the information provided by wholesalers) Permitted to distribute until Jun 29, 2024 Product suspended from the medicinal product register, distribution permitted for a limited time span |
currently no information on availability from any wholesaler |
N7 (16 mg/12,5 mg) |
PVC/PVDC/Al blister | 11-0413-02 | ||
| Not available (according to the information provided by wholesalers) | currently no information on availability from any wholesaler |
N14 (16 mg/12,5 mg) |
PVC/PVDC/Al blister | 11-0413-03 |
Labelling text Jul 25, 2023 Labelling text Jul 25, 2023 |
|
|
Not available (according to the information provided by wholesalers) Permitted to distribute until Jun 29, 2024 Product suspended from the medicinal product register, distribution permitted for a limited time span |
currently no information on availability from any wholesaler |
N15 (16 mg/12,5 mg) |
PVC/PVDC/Al blister | 11-0413-04 | ||
| Not available (according to the information provided by wholesalers) | currently no information on availability from any wholesaler |
N28 (16 mg/12,5 mg) |
PVC/PVDC/Al blister | € 27.40 | 11-0413-05 |
Labelling text Jul 25, 2023 Labelling text Jul 25, 2023 |
|
Not available (according to the information provided by wholesalers) Permitted to distribute until Jun 29, 2024 Product suspended from the medicinal product register, distribution permitted for a limited time span |
currently no information on availability from any wholesaler |
N28: 1 × 28 (16 mg/12,5 mg) |
PVC/PVDC/Al unit-dose blister | 11-0413-06 | ||
| Not available (according to the information provided by wholesalers) | currently no information on availability from any wholesaler |
N30 (16 mg/12,5 mg) |
PVC/PVDC/Al blister | 11-0413-07 |
Labelling text Jul 25, 2023 Labelling text Jul 25, 2023 |
|
|
Not available (according to the information provided by wholesalers) Permitted to distribute until Jun 29, 2024 Product suspended from the medicinal product register, distribution permitted for a limited time span |
currently no information on availability from any wholesaler |
N50 (16 mg/12,5 mg) |
PVC/PVDC/Al blister | 11-0413-08 | ||
|
Not available (according to the information provided by wholesalers) Permitted to distribute until Jun 29, 2024 Product suspended from the medicinal product register, distribution permitted for a limited time span |
currently no information on availability from any wholesaler |
N50: 1 × 50 (16 mg/12,5 mg) |
PVC/PVDC/Al unit-dose blister | 11-0413-09 | ||
| Not available (according to the information provided by wholesalers) | currently no information on availability from any wholesaler |
N56 (16 mg/12,5 mg) |
PVC/PVDC/Al blister | 11-0413-10 |
Labelling text Jul 25, 2023 Labelling text Jul 25, 2023 |
|
|
Not available (according to the information provided by wholesalers) Permitted to distribute until Jun 29, 2024 Product suspended from the medicinal product register, distribution permitted for a limited time span |
currently no information on availability from any wholesaler |
N56: 1 × 56 (16 mg/12,5 mg) |
PVC/PVDC/Al unit-dose blister | 11-0413-11 | ||
| Not available (according to the information provided by wholesalers) | currently no information on availability from any wholesaler |
N98 (16 mg/12,5 mg) |
PVC/PVDC/Al blister | 11-0413-12 |
Labelling text Jul 25, 2023 Labelling text Jul 25, 2023 |
|
|
Not available (according to the information provided by wholesalers) Permitted to distribute until Jun 29, 2024 Product suspended from the medicinal product register, distribution permitted for a limited time span |
currently no information on availability from any wholesaler |
N98: 1 × 98 (16 mg/12,5 mg) |
PVC/PVDC/Al unit-dose blister | 11-0413-13 | ||
|
Not available (according to the information provided by wholesalers) Permitted to distribute until Jun 29, 2024 Product suspended from the medicinal product register, distribution permitted for a limited time span |
currently no information on availability from any wholesaler |
N100 (16 mg/12,5 mg) |
PVC/PVDC/Al blister | 11-0413-14 | ||
|
Not available (according to the information provided by wholesalers) Permitted to distribute until Jun 29, 2024 Product suspended from the medicinal product register, distribution permitted for a limited time span |
currently no information on availability from any wholesaler |
N300 (16 mg/12,5 mg) |
PVC/PVDC/Al blister | 11-0413-15 | ||
| Not available (according to the information provided by wholesalers) | currently no information on availability from any wholesaler |
N90 (16 mg/12,5 mg) |
PVC/PVDC/Al blister | 11-0413-16 |
Labelling text Jul 25, 2023 Labelling text Jul 25, 2023 |
|
|
Not available (according to the information provided by wholesalers) Permitted to distribute until Jun 29, 2024 Product suspended from the medicinal product register, distribution permitted for a limited time span |
currently no information on availability from any wholesaler |
N15: 15 × 1 (16 mg/12,5 mg) |
PVC/PVDC/Al unit-dose blister | 11-0413-17 | ||
|
Not available (according to the information provided by wholesalers) Permitted to distribute until Jun 29, 2024 Product suspended from the medicinal product register, distribution permitted for a limited time span |
currently no information on availability from any wholesaler |
N30: 30 × 1 (16 mg/12,5 mg) |
PVC/PVDC/Al unit-dose blister | 11-0413-18 |
Registration information
| Marketing authorisation No. | 11-0413 |
|---|---|
| MA suspended from the medicinal product register by request of Cheplapharm Arzneimittel GmbH, Germany | Dec 29, 2023 |
| Permitted to distribute until | Jun 29, 2024 |
| Marketing authorisation holder, country | Cheplapharm Arzneimittel GmbH, Germany |
